NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44)

Jurisdiction:
Federal
Incentive Type:Grant Program
Industries:
Health And Safety, Technology
Eligible Sector:
Business
Category:
Financial Incentive
Time Period:
FY 2015
Governing Body:National Institutes of Health
What’s it worth?:Not mentioned

The NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention program prioritizes studies in the following areas:

  • Primary and secondary prevention stroke trials
  • Emergent management or acute stroke treatment trials
  • Neuro-recovery and rehabilitation stroke trials

The program gives preference to projects that are innovative and efficient such as:

  • Adaptive dose-finding designs
  • Plans for sample size recalculation
  • Futility designs
  • Early feasibility medical device designs
  • Traditional feasibility medical device designs

Exploratory Trials, Confirmatory Trials, and Biomarker and Clinical Endpoint Studies qualify for this funding opportunity. Grant awards typically range between $150,000 and $1,500,000 per project. Applicants are encourage to contact the NIH program officials before proposing anything in excess of the guidelines. All applicants must meet the following criteria:

Application packets may be obtained from the Grants.gov website and must be complete and submitted before the deadline. Applicants must registered with:

  • Dun and Bradstreet Universal Number System (DUNS)
  • System for Award Management (SAM)
  • SBA Company Registry
  • eRA Commons
  • Grants.gov

This program does not have any cost sharing requirements. Applications may include a Letter of Intent and must include:

  • SF424 Cover
  • SF424 Project Performance Site Locations
  • SF424 Other Project Information
  • SBA Company registry
  • SBIR Application Certification
  • SF424 Senior/Key Personnel Expanded Profile
  • Budget
  • Cover Page Supplement
  • Research Plan
  • Appendix

Applications must be complete and received before the deadline.